-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Surgery Partners, Raises Price Target to $19

Benzinga·08/11/2026 16:09:21
Listen to the news
TD Cowen analyst Ryan Langston maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $17 to $19.